Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02203604
Title High-Dose Aldesleukin and Ipilimumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed By Surgery
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Rutgers, The State University of New Jersey
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Loyola University Medical Center Maywood Illinois 60153 United States Details
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 United States Details
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey 08903 United States Details
Cleveland Clinic Cleveland Ohio 44195 United States Details
Providence Portland Medical Center Portland Oregon 97213 United States Details
Vanderbilt University Medical Center Nashville Tennessee 37240 United States Details
*Shaded cells indicate that there was no data available from for the field